Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Calidi Biotherapeutics Announces The Appointment of Medical Oncologist and Expert in Oncolytic Immunotherapies, Dr. Dmitriy Zamarin to Their Scientific Advisory Board
SAN DIEGO (PRWEB) JUNE 03, 2019 – Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at…
Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board
SAN DIEGO, May 30, 2019 /PRNewswire/ — Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces A Collaborative Study With The National Institutes Of Health (NIH) On The Therapeutic Potential Of Oncolytic Viruses Delivered By Mesenchymal Stem Cells
SAN DIEGO, May 28, 2019 /PRNewswire/ — Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at…
Calidi Biotherapeutics Releases Recent Interviews of CEO Allan Camaisa
SAN DIEGO (PRWEB) APRIL 15, 2019 Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the…
Calidi Biotherapeutics Launches Scientific and Medical Advisory Board
SAN DIEGO, Jan. 3, 2019 /PRNewswire-PRWeb/ — Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at…
Calidi Biotherapeutics, Inc. announces its corporate vision in groundbreaking cancer drug development and appoints Allan Camaisa as CEO
SAN DIEGO, May 24, 2018 — Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the…